Catalent to build a $40M analytical services facility in North Carolina's Research Triangle
Catalent is looking to make a further commitment in the Tar Heel State — and will be expanding its presence there.
The CDMO on Tuesday announced that it will build a new biologics analytical center in Durham, NC, a city just to the west of the capital and within the research triangle, a major area for drug manufacturing and laboratory work. The new facility will offer standalone analytical development and testing for biologics including cell and gene therapies.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters